Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens

被引：94

作者：

Jarvest, RL

Berge, JM

Berry, V

Boyd, HF

Brown, MJ

Elder, JS

Forrest, AK

Fosberry, AP

Gentry, DR

Hibbs, MJ

Jaworski, DD

O'Hanlon, PJ

Pope, AJ

Rittenhouse, S

Sheppard, RJ

Slater-Radosti, C

Worby, A

机构：

[1] GlaxoSmithKline, Harlow CM19 5AW, Essex, England

[2] GlaxoSmithKline, Collegeville, PA 19426 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2002年 / 45卷 / 10期

关键词：

D O I：

10.1021/jm025502x

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Potent nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase have been derived from a file compound high throughput screening hit. Optimized compounds show excellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics. Compound II demonstrated in vivo efficacy in an S. aureus rat abscess infection model.

引用

页码：1959 / 1962

页数：4

共 50 条

[21] Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei
Zhang, Zhongsheng
Barros-Alvarez, Ximena
Gillespie, J. Robert
Ranade, Ranae M.
Huang, Wenlin
Shibata, Sayaka
Molasky, Nora M. R.
Faghih, Omeed
Mushtaq, Aisha
Choy, Robert K. M.
de Hostos, Eugenio
Hol, Wim G. J.
Verlinde, Christophe L. M. J.
Buckner, Frederick S.
Fan, Erkang
RSC MEDICINAL CHEMISTRY, 2020, 11 (08): : 885 - 895
[22] Leukocyte defensin activity against gram-positive oral pathogens
Newsom, CL
Jefferson, MM
Thomas, EL
JOURNAL OF DENTAL RESEARCH, 2000, 79 : 227 - 227
[23] In vitro activities of peptide deformylase inhibitors against gram-positive pathogens
Wise, R
Andrews, JM
Ashby, J
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) : 1117 - 1118
[24] EXPERIENCE WITH CEFOTAXIME IN INFECTIONS CAUSED BY GRAM-POSITIVE PATHOGENS, ESPECIALLY STAPHYLOCOCCUS-AUREUS
FUJII, R
INFECTION, 1985, 13 : S9 - S13
[25] The antibacterial activity of a photoactivatable diarylacetylene against Gram-positive bacteria
Waite, Ryan
Adams, Candace T.
Chisholm, David R.
Sims, C. H. Cole
Hughes, Joshua G.
Dias, Eva
White, Emily A.
Welsby, Kathryn
Botchway, Stanley W.
Whiting, Andrew
Sharples, Gary J.
Ambler, Carrie A.
FRONTIERS IN MICROBIOLOGY, 2023, 14
[26] Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens
Olleik, Hamza
Yahiaoui, Samir
Roulier, Brayan
Courvoisier-Dezord, Elise
Perrier, Josette
Peres, Basile
Hijazi, Akram
Baydoun, Elias
Raymond, Josette
Boumendjel, Ahcene
Maresca, Marc
Haudecoeur, Romain
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 165 : 133 - 141
[27] Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity
Tanitame, A
Oyamada, Y
Ofuji, K
Suzuki, K
Ito, H
Kawasaki, M
Wachi, M
Yamagishi, J
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) : 2863 - 2866
[28] Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria
Ceballos, Sara
Kim, Choon
Ding, Derong
Mobashery, Shahriar
Chang, Mayland
Torres, Carmen
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (08)
[29] In Silico Identification of Potential Inhibitors against Staphylococcus aureus Tyrosyl-tRNA Synthetase
Monobe, Kohei
Taniguchi, Hinata
Aoki, Shunsuke
CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (05) : 452 - 462
[30] Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus
Lu, Yanran
Papa, Jonathan L.
Nolan, Sheri
English, Anthony
Seffernick, Justin T.
Shkolnikov, Nicholas
Powell, Josh
Lindert, Steffen
Wozniak, Daniel J.
Yalowich, Jack
Mitton-Fry, Mark J.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (12): : 2446 - 2454

← 1 2 3 4 5 →